论文部分内容阅读
为了探讨体外反搏治疗对血液流变学影响及其与疗效的关系,我部反搏室对30例心脑血管疾病患者进行了反搏前与反搏后血液流变学的对照观察,现报告如下。1资料与方法 30例中,男26例,女4例,平均年龄58.3岁,其中冠心病心绞痛18例,脑动脉硬化6例,脑血栓形成6例。正常对照组50例,其中男35例,女15例,年龄在44～68岁,平均52.7岁。本组采用广州医疗器械厂生产的WEB-Ⅳ型电脑控制增强型体外反搏装置治疗,
In order to investigate the impact of extracorporeal counterpulsation therapy on hemorheology and its relationship with the curative effect, our department of Echocardiography in 30 cases of cardiovascular and cerebrovascular disease patients before and after counterpulsation hemorheology control observation, and now The report is as follows. 1 Materials and Methods 30 cases, 26 males and 4 females, mean age 58.3 years, 18 cases of coronary heart disease angina, cerebral arteriosclerosis in 6 cases, cerebral thrombosis in 6 cases. Normal control group of 50 patients, 35 males and 15 females, aged 44 to 68 years, an average of 52.7 years old. The group uses the Guangzhou Medical Equipment Factory production WEB-Ⅳ-based computer-controlled enhanced EECP device treatment,